Sylvie Ranger‐Rogez

3.9k total citations
71 papers, 2.1k citations indexed

About

Sylvie Ranger‐Rogez is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Sylvie Ranger‐Rogez has authored 71 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 22 papers in Infectious Diseases and 13 papers in Oncology. Recurrent topics in Sylvie Ranger‐Rogez's work include Cytomegalovirus and herpesvirus research (17 papers), Herpesvirus Infections and Treatments (15 papers) and Viral-associated cancers and disorders (12 papers). Sylvie Ranger‐Rogez is often cited by papers focused on Cytomegalovirus and herpesvirus research (17 papers), Herpesvirus Infections and Treatments (15 papers) and Viral-associated cancers and disorders (12 papers). Sylvie Ranger‐Rogez collaborates with scholars based in France, Germany and Saudi Arabia. Sylvie Ranger‐Rogez's co-authors include V. Descamps, Sophie Alain, B. Crickx, Philippe Musette, F. Denis, Laurent Mardivirin, F. Denis, Dominique Bordessoule, Vincent Descamps and François Denis and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Sylvie Ranger‐Rogez

65 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Ranger‐Rogez France 24 912 672 538 438 411 71 2.1k
M. Rybojad France 28 925 1.0× 108 0.2× 761 1.4× 243 0.6× 492 1.2× 144 3.2k
Sharon K. Gershon United States 8 1.5k 1.7× 83 0.1× 1.1k 2.0× 281 0.6× 212 0.5× 9 3.9k
M Crovatto Italy 27 1.2k 1.4× 51 0.1× 315 0.6× 513 1.2× 645 1.6× 55 2.7k
J F Colombel United States 29 1.7k 1.8× 45 0.1× 421 0.8× 238 0.5× 114 0.3× 148 3.6k
Eric A. Vasiliauskas United States 35 2.3k 2.6× 78 0.1× 357 0.7× 216 0.5× 107 0.3× 96 4.7k
Shelley F. Stone Australia 21 722 0.8× 162 0.2× 114 0.2× 97 0.2× 40 0.1× 27 1.6k
Tsila Zuckerman Israel 24 410 0.4× 69 0.1× 79 0.1× 604 1.4× 205 0.5× 125 2.5k
John Kasznica United States 19 1.4k 1.5× 56 0.1× 705 1.3× 259 0.6× 150 0.4× 50 3.5k
Christophe Piketty France 30 1.5k 1.7× 43 0.1× 308 0.6× 401 0.9× 148 0.4× 116 3.7k
Adrian Ciurea Switzerland 30 320 0.4× 53 0.1× 1.7k 3.1× 130 0.3× 156 0.4× 104 2.9k

Countries citing papers authored by Sylvie Ranger‐Rogez

Since Specialization
Citations

This map shows the geographic impact of Sylvie Ranger‐Rogez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Ranger‐Rogez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Ranger‐Rogez more than expected).

Fields of papers citing papers by Sylvie Ranger‐Rogez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Ranger‐Rogez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Ranger‐Rogez. The network helps show where Sylvie Ranger‐Rogez may publish in the future.

Co-authorship network of co-authors of Sylvie Ranger‐Rogez

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Ranger‐Rogez. A scholar is included among the top collaborators of Sylvie Ranger‐Rogez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Ranger‐Rogez. Sylvie Ranger‐Rogez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Sylvain, et al.. (2025). Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples. PLoS ONE. 20(4). e0320978–e0320978. 2 indexed citations
2.
Ranger‐Rogez, Sylvie, et al.. (2023). Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays. Diagnostic Microbiology and Infectious Disease. 105(4). 115900–115900. 1 indexed citations
3.
Marcelin, Anne‐Geneviève, Diane Descamps, Catherine Tamalet, et al.. (2011). Emerging Mutations and Associated Factors in Patients Displaying Treatment Failure on An Etravirine-Containing Regimen. Antiviral Therapy. 17(1). 119–123. 7 indexed citations
4.
Descamps, V., Laurent Mardivirin, Baptiste Janela, Philippe Musette, & Sylvie Ranger‐Rogez. (2010). Le syndrome d’hypersensibilité (DRESS) n’est qu’une maladie virale. Revue française d'allergologie. 50(3). 171–173. 10 indexed citations
5.
Picard, D, Baptiste Janela, V. Descamps, et al.. (2010). Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response. Science Translational Medicine. 2(46). 46ra62–46ra62. 263 indexed citations
6.
Mardivirin, Laurent, et al.. (2007). Augmentation de la réplication in vitro de l’herpèsvirus humain 6 en présence de valproate de sodium. Virologie. 11(2). 151–153. 1 indexed citations
7.
Denes, É., H. Durox, A. Boumédiène, et al.. (2007). Méningo-encéphalite herpétique, aciclovir et maladie VIH, une histoire en 3 actes. Revue Neurologique. 163(3). 369–372.
8.
Couty, Ludovic, Jean-Christophe Szelag, Pascal Turlure, et al.. (2005). Multiplex real-time PCR assay for simultaneous quantitation of human cytomegalovirus and herpesvirus-6 in polymorphonuclear and mononuclear cells of transplant recipients. Journal of Virological Methods. 132(1-2). 77–84. 14 indexed citations
9.
Denis, François, et al.. (2004). [Seroprevalence of hepatitis A in hospitalized patients in Limoges University Hospital].. PubMed. 27(8-9). 727–31. 10 indexed citations
10.
Collot-Teixeira, Sophie, Juan I. Fuxman Bass, F. Denis, & Sylvie Ranger‐Rogez. (2004). Human tumor suppressor p53 and DNA viruses. Reviews in Medical Virology. 14(5). 301–319. 56 indexed citations
11.
Descamps, Vincent, E. Mahé, Nadira Houhou, et al.. (2003). Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. British Journal of Dermatology. 148(5). 1032–1034. 99 indexed citations
12.
Robert, Pierre‐Yves, et al.. (2002). Multiplex detection of herpesviruses in tear fluid using the “stair primers” pcr method: Prospective study of 93 patients. Journal of Medical Virology. 66(4). 506–511. 29 indexed citations
13.
Loustaud‐Ratti, V., Agnès Riché, Eric Liozon, et al.. (2001). Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study.. PubMed. 28(10). 2245–51. 69 indexed citations
14.
Alain, Sophie, et al.. (2001). Quantification par PCR en temps réel, technologie TaqMan et applications en virologie. Virologie. 5(6). 439–448.
15.
Ranger‐Rogez, Sylvie, et al.. (1999). Herpesvirus humains 6 et 7 (HHV-6 et HHV-7).. La Revue du praticien. 49(20).
16.
Ranger‐Rogez, Sylvie, et al.. (1997). Le virus herpès humain de type 6 (HHV-6) est-il impliqué dans la survenue de maladies auto-immunes ?. Virologie. 1(4). 301–312.
17.
Barrière, Éric, et al.. (1997). Virus associated with the gastrointestinal tract. Annales de biologie clinique. 55(4). 1 indexed citations
18.
Ranger‐Rogez, Sylvie, et al.. (1996). Evaluation of rapid culture centrifugation method for adenovirus detection in stools. Diagnostic Microbiology and Infectious Disease. 24(1). 25–29. 4 indexed citations
19.
Ranger‐Rogez, Sylvie, et al.. (1995). [Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach].. PubMed. 24(17). 803–6. 6 indexed citations
20.
Ranger‐Rogez, Sylvie, et al.. (1995). Enteric prevalence of adenovirus in human immunodeficiency virus seropositive patients. Journal of Medical Virology. 45(1). 56–60. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Rybojad Breakdown of academic impact, for papers by Sharon K. Gershon Breakdown of academic impact, for papers by M Crovatto Breakdown of academic impact, for papers by J F Colombel Breakdown of academic impact, for papers by Eric A. Vasiliauskas Breakdown of academic impact, for papers by Shelley F. Stone Breakdown of academic impact, for papers by Tsila Zuckerman Breakdown of academic impact, for papers by John Kasznica Breakdown of academic impact, for papers by Christophe Piketty Breakdown of academic impact, for papers by Adrian Ciurea
Rankless by CCL
2026